Experts discuss the importance of continuous, real-time monitoring in preclinical research, sharing case studies including using continuous EEG monitoring for sleep studies and using telemetry in Biodefense research.
During this exclusive webinar sponsored by Data Sciences International, Steve Fox, Associate Principal Scientist at Merck Research Labs, shares his experience from pharmaceutical development, discussing the importance of continuous EEG monitoring as a biomarker for CNS activity and drug discovery. Anna Honko, Staff Scientist at NIH/NIAID, explains the importance of having access to real-time, continuous data when studying infectious diseases in non-human primates in a Biodefense setting. In addition, Dusty Sarazan, CSO at Data Sciences International, reminds viewers how and why continuous, real-time monitoring has become not only the preferred, but essential method, for acquiring and studying physiology in today's preclinical research setting.
Presenters
Anna Honko
Anna Honko, PhD recently joined Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) as a Research Associate Professor. In the Nonclinical Studies Unit, she’ll be directing well-documented, Animal Rule and GLP studies to advance anti-viral medical countermeasure development. Dr. Honko's background is in immunology and vaccine development, with a later emphasis in biothreat and emerging infectious diseases. She has a focus on regulated studies as well a passion for radiotelemetry monitoring.
Sponsor
Data Sciences International
